Ph.D. candidate Kumar Kulldeep Niloy was awarded one of the three coveted trainee awards at the Fourteenth American Conference on Pharmacometrics (ACoP14) held from November 5-8 in National Harbor, Maryland. Kumar was honored for his groundbreaking work on preclinical tumor growth inhibition modeling, conducted under Dr. Markos Leggas’s guidance at St. Jude Children’s Research Hospital.
Kumar Kulldeep Niloy, an outstanding Ph.D. candidate in our graduate program in Pharmaceutical Sciences, was recently awarded one of the three coveted trainee awards at the Fourteenth American Conference on Pharmacometrics (ACoP14) held from November 5-8 in National Harbor, Maryland.
This award was presented to him in recognition of his groundbreaking work on preclinical tumor growth inhibition modeling, which aims to develop a synergistic combination therapy for Ewing sarcoma. His exceptional research was carried out under the guidance of Dr. Markos Leggas at St. Jude Children’s Research Hospital.
Latest Posts
- Recent PhD Graduate Dr. Paridhi Gupta Receives the Trainee Award at the American Conference on Pharmacometrics
- Professors Hevener and Hamilton Inducted into UTHSC’s Academy of Master Educators
- Professor Joana Hudson Awarded “Outstanding Paper of the Year by ACCP Ambulatory Care Practice and Research Networks
- P4 PharmD Student Mateo Lopez Awarded Professionalism Award
- Faculty Members Cernasev and Barenie Awarded “Best Manuscript” by Clinics and Practice Journal